Biotage logo

Biotage

Action
Action
ISIN: SE0000454746
Ticker: BIOT
SE0000454746
BIOT

Price

Prix

GRAPH PAR

Dividendes historiques et prévisions

 


0,114

GRAPH PAR

Questions fréquentes

Biotage's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0,323. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover Biotage's stock, with a consensus target price of 14,63 $US. Analyst ratings provide insights into the stock's expected performance.
Au cours des douze derniers mois, Biotage a déclaré un revenu de 197,91 M $US.
Le bénéfice avant intérêts, impôts et amortissements (EBITDA) de Biotage sur les douze derniers mois est de 47,13 M $US. L'EBITDA mesure la performance financière globale de l'entreprise.
Biotage a un flux de trésorerie disponible de 26,64 M $US. Le flux de trésorerie disponible indique les liquidités générées après comptabilisation des sorties de trésorerie destinées à soutenir les opérations et les immobilisations.
Biotage emploie environ 673 personnes. Elle opère dans le secteur Soins de santé, plus précisément dans l'industrie Spécialités médicales.

Finances

BPA (TTM) 
0,323
Recettes (TTM) 
197,91 M $US
EBITDA (TTM) 
47,13 M $US
Cash-flow disponible (TTM) 
26,64 M $US

Notes des analystes

L'objectif de prix est de 14,63 $US et l'action est analysée par 1 analystes.

Acheter

0

Hold

1

Vendre

0

Informations

Biotage AB is a Swedish life science company specializing in advanced laboratory technologies and workflow solutions that support drug discovery, development, and analytical testing to improve human health. The company is based in Uppsala, Sweden. The company offers a comprehensive portfolio of systems, consumables, reagents, and accessories focused on chemical synthesis, purification, evaporation, and sample extraction and clean-up. Product categories include organic and peptide synthesis, biomolecule purification, flash chromatography, solid-phase and supported liquid extraction, filtration, and evaporation technologies. Biotage provides automated sample preparation workstations, advanced peptide synthesizers, specialized solid-supported reagents, chromatography resins, prepacked columns, cartridges, and plates for various purification needs. The company's solutions are used in bioanalysis, forensic toxicology, environmental testing, food safety, doping control, and biomolecule purification, and are supported by knowledge resources, customer service, application support, and software tools. The company serves customers in pharmaceutical, biotech, contract research and manufacturing, clinical, forensic, academic laboratories, and organizations focused on food safety, clean water, and environmental sustainability. and has a global presence of subsidiaries in several regions. The company was founded in 1969 by Bengt Falk, Bertil Pettersson, Björn Lennart Ekström, Carl Erik Mathias Uhlén, Mostafa Ronaghi, Neil Goldsmith, Pal Nyrén, Sheridan G. Snyder. Frederic Vanderhaegen has been the CEO of the company since 2024.

Salariés
673
Industries
Spécialités médicales
Secteur
Soins de santé

Identifiant

ISIN
SE0000454746
Ticker primaire
BIOT

Les Knockouts

Données en temps réel par LSX · Données financières de FactSet
Participez à la discussion